0001654954-24-012011.txt : 20240917 0001654954-24-012011.hdr.sgml : 20240917 20240917124148 ACCESSION NUMBER: 0001654954-24-012011 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240917 FILED AS OF DATE: 20240917 DATE AS OF CHANGE: 20240917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Haleon plc CENTRAL INDEX KEY: 0001900304 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41411 FILM NUMBER: 241303369 BUSINESS ADDRESS: STREET 1: BUILDING 5, FIRST FLOOR STREET 2: THE HEIGHTS CITY: WEYBRIDGE STATE: X0 ZIP: KT13 0NY BUSINESS PHONE: 44 1932 822000 MAIL ADDRESS: STREET 1: BUILDING 5, FIRST FLOOR STREET 2: THE HEIGHTS CITY: WEYBRIDGE STATE: X0 ZIP: KT13 0NY FORMER COMPANY: FORMER CONFORMED NAME: DRVW 2022 Ltd DATE OF NAME CHANGE: 20211217 6-K 1 a5765e.htm TRANSACTION IN OWN SHARES a5765e

 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2024
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
 17 September 2024 - “Transaction in Own Shares”
 
 
 
 
99.1
 
 
 
 
 
Haleon plc: Transaction in own shares
 
17 September 2024: Haleon plc (the “Company” or “Haleon”) today announces the purchase of the following number of ordinary shares of £0.01 each in the Company (the “Shares”) for cancellation under its share buyback programme announced on 1 August 2024 (the “Buyback Programme”).
 
Date of purchase:
17 September 2024
Number of Shares purchased:
645,140
Highest price paid per Share (p):
397.9000
Lowest price paid per Share (p):
394.8000
Volume weighted average price paid per Share (p):
396.4085
 
Following the settlement of the above, the Company's registered share capital consists of 9,117,826,432 ordinary shares. This figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5s(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/5763E_1-2024-9-17.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
Sonya Ghobrial
+44 7392 784784
Zoë Bird
+44 7736 746167
Rakesh Patel
+44 7552 484646
Gemma Thomas
+44 7985 175048
Emma White
+44 7823 523562
 
 
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com. 
 
 
 
 
 
 
 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 17, 2024
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary